✦ LIBER ✦

THE DEVELOPMENT OF A NUMERICAL MASS TRANSPORT MODEL FOR DRUG ELUTING STENTS

✍ Scribed by Barry M O'Connell; Tim M McGloughlin; Michael T Walsh

Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 100 KB
Volume: 41
Category: Article
ISSN: 0021-9290
DOI: 10.1016/s0021-9290(08)70388-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel-eluting stents for the treatm

Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: A strategy of extensive lesion coverage with drug-eluting stents

✍ Gerald S. Werner; Gero Schwarz; Dirk Prochnau; Michael Fritzenwanger; Andreas Kr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 2 views

A theoretical model to characterize the

A theoretical model to characterize the drug release behavior of drug-eluting stents with durable polymer matrix coating

✍ Hugh Q. Zhao; Dudley Jayasinghe; Syed Hossainy; Lewis B. Schwartz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 2 views

## Abstract The time‐dependent local drug delivery from drug‐eluting stents (DES) plays a critical role in reducing restenosis in intravascular stenting. To better understand the basic mechanism of drug release for certain polymer‐drug‐coated DES platforms, a cylindrical diffusion model was applied

Development of a novel biocompatible pol

Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent

✍ Kishore Udipi; Mingfei Chen; Peiwen Cheng; Kevin Jiang; Diane Judd; Alejandra Ca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 2 views

## Abstract Drug‐eluting stents have proven superior to bare metal stents with lower restenosis rates. Local delivery of drugs from these stents is achieved in most cases with the help of biostable polymer coatings. However, since the polymer coating remains in the body well after all the drug is r

Late stent thrombosis: Considerations an

Late stent thrombosis: Considerations and practical advice for the use of drug-eluting stents: A report from the Society for Cardiovascular Angiography and Interventions drug-eluting stent task force

✍ John McB. Hodgson; Gregg W. Stone; A. Michael Lincoff; Lloyd Klein; Howard Walpo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Outcomes after differential use of drug-

Outcomes after differential use of drug-eluting stents in diabetic patients: 1-Year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry

✍ Ibrahim Akin; Alexander Bufe; Lars Eckardt; Holger Reinecke; Gert Richardt; Karl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

A dissolution-diffusion model for the TA

A dissolution-diffusion model for the TAXUS™ drug-eluting stent with surface burst estimated from continuum percolation

✍ Victor Barocas; William Drasler II; Tim Girton; Ismail Guler; David Knapp; Jeff 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB 👁 2 views

## Abstract A two‐layer dissolution‐diffusion model is derived which incorporates a surface burst component that is estimated from continuum percolation models of overlapping Poisson distributed spheres. The model is shown to adequately describe the release properties of paclitaxel from a hydrophob